We are live on
!
Find out more
Zevra Therapeutics
ZVRA
ZVRA
38 hedge funds and large institutions have $5.86M invested in Zevra Therapeutics in 2019 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 8 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
350% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 2
100% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 4
19% more funds holding
Funds holding: 32 → 38 (+6)
58% less capital invested
Capital invested by funds: $13.9M → $5.86M (-$8.04M)
Holders
38
Holders Change
+6
Holders Change %
+18.75%
% of All Funds
0.83%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
9
Increased
8
Reduced
4
Closed
2
Calls
$13K
Puts
–
Net Calls
+$13K
Net Calls Change
-$36K
Top Buyers
Top Sellers
| 1 |
Alyeska Investment Group
Chicago,
Illinois
|
-$748K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$39.9K |
| 3 |
Janney Montgomery Scott
Philadelphia,
Pennsylvania
|
-$24K |
| 4 |
Morgan Stanley
New York
|
-$10.3K |
| 5 |
BlackRock
New York
|
-$3.69K |